Michel Alchoueiry

7PUBLICATIONS
64CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 20, 2026
mTORC1 activation induces B7-H3-dependent metabolic reprogramming in renal cell carcinoma (RCC).

|Sep 06, 2025
Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma.

Samer Salem, Tiegang Han, Michel Alchoueiry

|Jul 02, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.

Chris Labaki, Eddy Saad, Katrine N Madsen

|Jan 09, 2024
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex.

Nicola Alesi, Damir Khabibullin, Dean M Rosenthal

|Jan 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.

Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca

|Jul 22, 2022
Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11.

Long Zhang, Charbel S Hobeika, Damir Khabibullin

Pageof 2

Frequent Collaborators

7 joint publications

Elizabeth P Henske

2 joint publications

Damir Khabibullin

2 joint publications

Samer Salem

2 joint publications

Toni K Choueiri